Keratosis
MONDO:0006566A skin disorder consisting of hypertrophy of the stratum corneum of the skin.
Also known as: keratoderma
30 clinical trials for this condition and its sub-types, 5 tagged with Keratosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Keratosis
-
Palmoplantar keratosis 4 trials · 16 incl. sub-types
2 sub-types
- Hereditary palmoplantar keratoderma 0 trials · 13 incl. sub-types Sub-types →
- Aquagenic palmoplantar keratoderma 1 trial
-
Seborrheic keratosis 6 trials
5 sub-types
- Eyelid seborrheic keratosis 0 trials
- Inflamed seborrheic keratosis 0 trials
- Inverted follicular keratosis 0 trials Sub-types →
- Melanoacanthoma 0 trials
- Vulvar seborrheic keratosis 0 trials Sub-types →
-
Cholesteatoma 1 trial · 3 incl. sub-types
3 sub-types
- Cholesteatoma of middle ear 2 trials Sub-types →
- Cholesteatoma of external ear 0 trials
- Maxillary sinus cholesteatoma 0 trials
-
Acrokeratosis verruciformis 1 trial
-
Acquired keratosis 0 trials
-
2 sub-types
-
Porokeratosis 0 trials
4 sub-types
- Disseminated superficial actinic porokeratosis 0 trials Sub-types →
- Linear porokeratosis 0 trials
- Porokeratosis of Mibelli 0 trials Sub-types →
- Porokeratosis plantaris palmaris et disseminata 0 trials
-
Trichostasis spinulosa 0 trials
Most studied deeper sub-types
-
Could a cancer pill ease rare, painful skin diseases?
Disease control Not yet recruitingThis early-phase trial tests whether low doses of erlotinib, a drug originally used for cancer, can improve symptoms of rare genetic skin conditions called keratinopathies. About 44 adults with confirmed diagnoses will take increasing doses over 24 weeks. The goal is to see if it…
Phase 1/2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Freeze then ointment: new combo tackles precancerous skin spots
Disease control Not yet recruitingThis study tests whether freezing precancerous skin spots (cryotherapy) followed by a medicated ointment (tirbanibulin) works better than freezing alone for actinic keratosis on the scalp and forehead. About 59 adults with at least 8 spots will receive the combo treatment or a pl…
Phase 3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a supplement boost prostate cancer treatment?
Disease control Not yet recruitingThis early-phase trial tests whether adding a dietary supplement called LC-K76 to standard hormone therapy is safe for men with metastatic hormone-sensitive prostate cancer. Forty men will receive the supplement plus hormone therapy for 24 weeks, then be followed for another 24 w…
Early phase 1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can AI read skin biopsies as well as expert pathologists?
Diagnosis Not yet recruitingThis study asks whether an artificial intelligence algorithm can accurately diagnose seborrheic keratosis—a common, non-cancerous skin growth—from tissue samples. Researchers will compare the AI's performance against certified dermatopathologists using 30 preserved slides. The go…
Sponsor: Al-Azhar University • Aim: Diagnosis
Last updated Aug 28, 2026 00:00 UTC
-
New study aims to find best way to measure foot calluses in diabetes
Diagnosis Not yet recruitingThis study compares several non-invasive methods to measure foot calluses (plantar hyperkeratosis) in 50 people, half with diabetes and half without. The goal is to find the most reliable technique for assessing callus hardness and stiffness, which could help prevent foot ulcers …
Sponsor: University of Seville • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
New test may predict prostate cancer treatment success
Knowledge-focused Not yet recruitingThis study looks at whether a test called minimal residual disease (MRD) can help predict how well treatment works in men with metastatic hormone-sensitive prostate cancer. Researchers will track 50 newly diagnosed patients to see how different gene patterns affect treatment resp…
Sponsor: Anhui Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC